If you want to know our biggest future

New Post Public Reply Private Reply Replies (2) Message Board
Goosebumps
720
If you want to know our biggest future competition…

Nice read on CCR5 now and the future with Crispr… gene editing. I have always thought that the window of monoclonal antibodies is until we figure out gene editing and just what every gene is exactly for and if we need it or not. We have discovered and mapped the DNA strand and know a lot now but the next 10-15 years Crispr will be editing and stopping all disease in my opinion.

There may be some use for certain mabs in 15-20 years but Crispr is our future of very much precision medicine coming. If you don’t know about Crispr it is important for everyone to do their proper D&D and know what is our future medicine looks like.

Here is a 4 minute video from 60 minutes on Harvard Professor and his universities program on Crispr. As a introduction to Crispr.

https://youtu.be/12VfS2hAi7c

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Celebrating Excellence in Actuarial Science: SCOR Awards 2025

Updated Category News Views 116

SCOR’s Actuarial Awards 2025: A Celebration of Innovation For nearly 30 years, SCOR has consistently honored exemplary research in actuarial science through its prestigious Actuarial Awards. Across six countries, these awards seek to inspire progress in the field, fostering advancements that improve our understanding of risk. Encouraging Research and Excellence The SCOR...

Continue Reading
Gentex Corporation Announces Earnings Release Date for 2024

Updated Category News Views 190

Gentex Corporation Announces Fourth Quarter Earnings Release Gentex Corporation (NASDAQ: GNTX), a prominent supplier of advanced technology solutions including digital vision and connected car systems, has scheduled the release of its financial results for the fourth quarter and the year-end of 2024. Investors and stakeholders should mark their calendars for January 31,...

Continue Reading
Lockton's Strategic Move in Saudi Arabia with New Leadership

Updated Category News Views 197

Lockton's Expansion into Saudi Arabia Kansas City, Mo. – Lockton, recognized as the foremost privately held independent insurance brokerage, has embarked on a significant journey by expanding its operations into Saudi Arabia. This strategic move marks an essential development for Lockton, as it enhances its presence in the Middle East and aligns with its overarching...

Continue Reading
Revolutionizing Defense: AMIAD and Dassault Aviation Unite

Updated Category News Views 158

Partnership Between AMIAD and Dassault Aviation Leading the Way in Defense Innovation At a recent aerospace gathering, a significant partnership was forged as Pascale Lohat, the Senior Executive VP of Engineering at Dassault Aviation, and Bertrand Rondepierre, Director of the French Agency for AI in Defense (AMIAD), came together to sign a memorandum of understanding....

Continue Reading
Innovative Trauma Solutions by Globus Medical Enhance Patient Care

Updated Category News Views 133

Globus Medical, Inc. (NYSE: GMED) made waves in the orthopedic trauma sector back in 2024 with some heavy-hitting product launches. They introduced several groundbreaking systems, including the TENSOR™ Suture Button System—their first foray into suture-based innovations, which snagged 510(k) clearance from the FDA. You know that buzz on the trading floor? It was...

Continue Reading